| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/13/2023 | Cidara Therapeutics, Inc. | CDTX | Sale | Common Stock | 4.3k | $1.53 | $6.6k | | 03/13/2023 |
| 03/31/2022 | Cidara Therapeutics, Inc. | CDTX | Grant | Employee Stock Option (right to buy) | 70k | $0.83 | $58.1k | | 03/31/2022 |
| 03/31/2022 | Cidara Therapeutics, Inc. | CDTX | Grant | Common Stock | 35k | $0.00 | $0 | | 03/31/2022 |
| 03/31/2022 | Cidara Therapeutics, Inc. | CDTX | Grant | Common Stock | 69k | $0.00 | $0 | | 03/31/2022 |
| 03/31/2022 | Cidara Therapeutics, Inc. | CDTX | Payment of Exercise | Common Stock | 23.1k | $0.83 | $19.2k | | 03/31/2022 |
| 08/25/2021 | Cidara Therapeutics, Inc. | CDTX | Grant | Stock Option (right to buy) | 250k | $2.16 | $540k | | 08/25/2021 |
| 05/29/2020 | BELLICUM PHARMACEUTICALS, INC | BLCM | Payment of Exercise | Common Stock | 107 | $7.63 | $816.4 | | 05/29/2020 |
| 04/08/2020 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Restricted Stock Units | 21.9k | $0.00 | $0 | | 04/08/2020 |
| 02/03/2020 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Stock Option (right to buy) | 410k | $1.36 | $557.6k | | 02/03/2020 |
| 08/29/2019 | BELLICUM PHARMACEUTICALS, INC | BLCM | Purchase | Common Stock | 8k | $1.23 | $9.8k | | 08/29/2019 |
| 06/11/2019 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Stock Option (right to buy) | 45k | $1.87 | $84.2k | | 06/11/2019 |
| 05/29/2019 | BELLICUM PHARMACEUTICALS, INC | BLCM | Payment of Exercise | Common Stock | 1.1k | $2.09 | $2.2k | | 05/29/2019 |
| 02/01/2019 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Stock Option (right to buy) | 45k | $3.35 | $150.8k | | 02/01/2019 |
| 05/29/2018 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Employee Stock Option (right to buy) | 120k | $7.95 | $954k | | 05/29/2018 |
| 05/29/2018 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Common Stock | 10k | $0.00 | $0 | | 05/29/2018 |
| 02/08/2018 | Aravive, Inc. | ARAV | Sale | Common Stock | 4.1k | $1.80 | $7.4k | | 02/08/2018 |
| 12/20/2017 | Aravive, Inc. | ARAV | Grant | Common Stock | 93.1k | $0.00 | $0 | | 12/20/2017 |
| 11/28/2017 | Aravive, Inc. | ARAV | Grant | Common Stock | 20k | $0.00 | $0 | | 11/28/2017 |
| 10/19/2017 | Aravive, Inc. | ARAV | Sale | Common Stock | 776 | $2.55 | $2k | | 10/19/2017 |
| 03/15/2017 | Aravive, Inc. | ARAV | Sale | Common Stock | 776 | $19.02 | $14.8k | | 03/14/2017 |
| 03/14/2017 | Aravive, Inc. | ARAV | Sale | Common Stock | 1.3k | $19.00 | $24k | | 03/14/2017 |
| 01/30/2017 | Aravive, Inc. | ARAV | Sale | Common Stock | 1.5k | $13.85 | $20.4k | | 01/27/2017 |
| 01/27/2017 | Aravive, Inc. | ARAV | Grant | Common Stock | 20.6k | $0.00 | $0 | | 01/27/2017 |
| 01/27/2017 | Aravive, Inc. | ARAV | Grant | Stock Option (Right to Buy) | 46.2k | $14.30 | $660.7k | | 01/27/2017 |